These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 11848688)
1. Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain. Mesulam M; Guillozet A; Shaw P; Quinn B Neurobiol Dis; 2002 Feb; 9(1):88-93. PubMed ID: 11848688 [TBL] [Abstract][Full Text] [Related]
2. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability. Wright CI; Geula C; Mesulam MM Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355 [TBL] [Abstract][Full Text] [Related]
3. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission. Duysen EG; Li B; Darvesh S; Lockridge O Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517 [TBL] [Abstract][Full Text] [Related]
4. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase. Pacheco G; Palacios-Esquivel R; Moss DE J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741 [TBL] [Abstract][Full Text] [Related]
5. Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Mesulam MM; Guillozet A; Shaw P; Levey A; Duysen EG; Lockridge O Neuroscience; 2002; 110(4):627-39. PubMed ID: 11934471 [TBL] [Abstract][Full Text] [Related]
6. Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity. Hartmann J; Kiewert C; Duysen EG; Lockridge O; Greig NH; Klein J J Neurochem; 2007 Mar; 100(5):1421-9. PubMed ID: 17212694 [TBL] [Abstract][Full Text] [Related]
7. Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice. Girard E; Bernard V; Minic J; Chatonnet A; Krejci E; Molgó J Life Sci; 2007 May; 80(24-25):2380-5. PubMed ID: 17467011 [TBL] [Abstract][Full Text] [Related]
8. Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain). Déniz-Naranjo MC; Muñoz-Fernández C; Alemany-Rodríguez MJ; del Carmen Pérez-Vieitez M; Aladro-Benito Y; Irurita-Latasa J; Sánchez-García F Neurosci Lett; 2007 Oct; 427(1):34-8. PubMed ID: 17923322 [TBL] [Abstract][Full Text] [Related]
9. Butyrylcholinesterase-rich neurons in rat brain demonstrated by a sensitive histochemical method. Tago H; Maeda T; McGeer PL; Kimura H J Comp Neurol; 1992 Nov; 325(2):301-12. PubMed ID: 1281176 [TBL] [Abstract][Full Text] [Related]
10. Butyrylcholinesterase in the life cycle of amyloid plaques. Guillozet AL; Smiley JF; Mash DC; Mesulam MM Ann Neurol; 1997 Dec; 42(6):909-18. PubMed ID: 9403484 [TBL] [Abstract][Full Text] [Related]
12. In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses. Kuhl DE; Koeppe RA; Snyder SE; Minoshima S; Frey KA; Kilbourn MR Ann Neurol; 2006 Jan; 59(1):13-20. PubMed ID: 16278840 [TBL] [Abstract][Full Text] [Related]
13. Histochemical mapping of acetylcholinesterase and butyrylcholinesterase in the medulla oblongata and pons of squirrel (Funambulus palmarum). Bhatt DK; Tewari HB J Neurosci Res; 1978; 3(5-6):419-39. PubMed ID: 739561 [TBL] [Abstract][Full Text] [Related]
14. Butyrylcholinesterase: impact on symptoms and progression of cognitive impairment. Tasker A; Perry EK; Ballard CG Expert Rev Neurother; 2005 Jan; 5(1):101-6. PubMed ID: 15853480 [TBL] [Abstract][Full Text] [Related]
15. Cholinesterase activity of human lung tumours varies according to their histological classification. Martínez-Moreno P; Nieto-Cerón S; Torres-Lanzas J; Ruiz-Espejo F; Tovar-Zapata I; Martínez-Hernández P; Rodríguez-López JN; Vidal CJ; Cabezas-Herrera J Carcinogenesis; 2006 Mar; 27(3):429-36. PubMed ID: 16272577 [TBL] [Abstract][Full Text] [Related]
16. Effects of acetylcholinesterase and butyrylcholinesterase inhibition on breathing in mice adapted or not to reduced acetylcholinesterase. Boudinot E; Taysse L; Daulon S; Chatonnet A; Champagnat J; Foutz AS Pharmacol Biochem Behav; 2005 Jan; 80(1):53-61. PubMed ID: 15652380 [TBL] [Abstract][Full Text] [Related]
17. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. Li B; Sedlacek M; Manoharan I; Boopathy R; Duysen EG; Masson P; Lockridge O Biochem Pharmacol; 2005 Nov; 70(11):1673-84. PubMed ID: 16213467 [TBL] [Abstract][Full Text] [Related]
18. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis. Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953 [TBL] [Abstract][Full Text] [Related]
19. Cholinesterases in normal and Alzheimer's disease primary olfactory gyrus. Hamodat H; Cash MK; Fisk JD; Darvesh S Neuropathol Appl Neurobiol; 2017 Dec; 43(7):571-583. PubMed ID: 28644906 [TBL] [Abstract][Full Text] [Related]
20. Electron microscopic localization of cholinesterase activity in Alzheimer brain tissue. Carson KA; Geula C; Mesulam MM Brain Res; 1991 Feb; 540(1-2):204-8. PubMed ID: 2054612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]